These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 3733419)
1. Vascular responses of platelet-activating factor in the Cebus apella primate and inhibitory profiles of antagonists SRI 63-072 and SRI 63-119. Handley DA; Van Valen RG; Saunders RN Immunopharmacology; 1986 Jun; 11(3):175-82. PubMed ID: 3733419 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of PAF-induced systemic responses in the rat, guinea pig, dog and primate by the receptor antagonist SRI 63-441. Handley DA; Tomesch JC; Saunders RN Thromb Haemost; 1986 Aug; 56(1):40-4. PubMed ID: 3775689 [TBL] [Abstract][Full Text] [Related]
3. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist. Herbert JM; Bernat A; Valette G; Gigo V; Lale A; LaPlace MC; Lespy L; Savi P; Maffrand JP; Le Fur G J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029 [TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo pharmacological profiles of the PAF receptor antagonist SRI 63-675. Handley DA; Van Valen RG; Winslow CM; Tomesch JC; Saunders RN Thromb Haemost; 1987 Apr; 57(2):187-90. PubMed ID: 3037718 [TBL] [Abstract][Full Text] [Related]
5. Biological effects of the orally active platelet activating factor receptor antagonist SDZ 64-412. Handley DA; Van Valen RG; Melden MK; Houlihan WJ; Saunders RN J Pharmacol Exp Ther; 1988 Nov; 247(2):617-23. PubMed ID: 3183958 [TBL] [Abstract][Full Text] [Related]
6. Evidence for a direct effect on vascular permeability of platelet-activating factor induced hemoconcentration in the guinea pig. Handley DA; Lee ML; Saunders RN Thromb Haemost; 1985 Dec; 54(4):756-9. PubMed ID: 4089809 [TBL] [Abstract][Full Text] [Related]
7. Effect of indomethacin and dazoxiben on intravascular platelet aggregation in the anaesthetized rabbit. Honey AC; Lad N; Tuffin DP Thromb Haemost; 1986 Aug; 56(1):80-5. PubMed ID: 3775692 [TBL] [Abstract][Full Text] [Related]
9. Inhibition by SRI 63-072 and SRI 63-119 of PAF-acether and immune complex effects in the guinea pig. Handley DA; Anderson RC; Saunders RN Eur J Pharmacol; 1987 Sep; 141(3):409-16. PubMed ID: 2959489 [TBL] [Abstract][Full Text] [Related]
11. Differential effects of WEB 2086 and SRI 63-441 on TNF-alpha-induced alterations in cardiopulmonary function. Kruse-Elliott KT; Dodam JR; Johnson LW; Olson NC Am J Physiol; 1992 Sep; 263(3 Pt 2):H761-70. PubMed ID: 1415600 [TBL] [Abstract][Full Text] [Related]
12. Administration of a receptor antagonist for platelet-activating factor during equine endotoxaemia. Carrick JB; Morris DD; Moore JN Equine Vet J; 1993 Mar; 25(2):152-7. PubMed ID: 8385601 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of rhesus monkey airway and cutaneous responses to platelet-activating factor (PAF) (AGEPC) with the anti-PAF agent SRI 63-072. Patterson R; Harris KE; Lee ML; Houlihan WJ Int Arch Allergy Appl Immunol; 1986; 81(3):265-8. PubMed ID: 3770978 [TBL] [Abstract][Full Text] [Related]
14. Action of platelet-activating factor (PAF) antagonists on the bronchopulmonary effects of PAF in the guinea-pig. Pons F; Touvay C; Lejeune V; Carré C; Vilain B; Broquet C; Mencia-Huerta JM; Braquet P J Lipid Mediat; 1989; 1(6):329-40. PubMed ID: 2519901 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological properties of YM461, a new orally active platelet-activating factor antagonist. Yamada T; Saito M; Mase T; Hara H; Nagaoka H; Murase K; Tomioka K Lipids; 1991 Dec; 26(12):1179-83. PubMed ID: 1668114 [TBL] [Abstract][Full Text] [Related]
17. Platelet-activating factor (PAF) inhibitory profile of KO-286011 on blood platelets in vitro and in vivo. Ostermann G; Hofmann B; Kertscher HP; Till U Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec; 342(6):713-8. PubMed ID: 2096302 [TBL] [Abstract][Full Text] [Related]
18. Equine peritoneal macrophage production of thromboxane and prostacyclin in response to platelet activating factor and its receptor antagonist SRI 63-441. Morris DD; Moore JN Circ Shock; 1989 Jun; 28(2):149-58. PubMed ID: 2544315 [TBL] [Abstract][Full Text] [Related]
19. Involvement of nitric oxide and eicosanoids in platelet-activating factor-induced haemodynamic and haematological effects in dogs. Noguchi K; Matsuzaki T; Shiroma N; Ojiri Y; Sakanashi M Br J Pharmacol; 1996 Jun; 118(4):941-50. PubMed ID: 8799566 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist. Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]